FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutics, specifically to a method of producing an aqueous composition sterilized by heating and containing solubilised chitosan and glycerol, where said composition is a transparent and viscous solution with pH from 6 to 7,5, wherein said method includes the following steps: (i) solubilising chitosan with average molecular weight of 10 to 250 kDa and degree of deacetylation greater than 60 % in an aqueous solution of a weak acid having a carboxyl group, wherein molar ratio of carboxyl group (-COOH) of said weak acid to amino group (-NH2) of said chitosan ranges from 1:0.9 to 1:1.1; (ii) adding glycerol; (iii) bringing pH to 6–7,5 by adding an aqueous solution of a weak base; and (iv) steam sterilization. Invention also relates to pharmaceutical aqueous compositions of sterilized chitosan.
EFFECT: group of inventions enables to obtain transparent viscous compositions with pH of 6-7,5 without formation of aggregates or precipitate.
29 cl, 5 dwg, 2 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
OPHTHALMIC GEL BIMATOPROST, WHICH IS APPLIED IN FORM OF DROPS | 2016 |
|
RU2698456C2 |
APPLICATION OF VISCOELASTIC FLUID TO OBTAIN MEDICAL PRODUCT FOR SURGICAL TREATMENT OF EYES | 2012 |
|
RU2603489C2 |
STABILIZED HYALURONIC ACID | 2019 |
|
RU2805502C2 |
AQUEOUS AEROSOL PREPARATION | 2004 |
|
RU2363449C2 |
THERMOSET NEUTRALISED CHITOSAN COMPOSITION FORMING HYDROGEL, ITS LYOPHILISATE AND METHODS FOR MAKING | 2005 |
|
RU2385710C1 |
DERMAL FILLER COMPOSITION FOR SMALL WRINKLES TREATING | 2012 |
|
RU2626513C2 |
CHITOSAN COMPOSITION | 2011 |
|
RU2605266C2 |
LOCAL HEMOSTATIC AGENT | 2013 |
|
RU2519220C1 |
COMPOSITION WITH HYALURONIC ACID AND METHOD FOR ITS PREPARATION | 2022 |
|
RU2794886C1 |
Authors
Dates
2020-01-28—Published
2015-10-28—Filed